Dénes Csonka (Denes Csonka)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Reduced Graphene Oxide

Pulmonary Arterial Hypertension

Placebo Controlled

Top Venues

Pharmacology research & perspectives

Clinical drug investigation

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer Lynn Ford, Ahad Sabet, Jaya Natarajan, Hans Stieltjes, Daniel L Chao, Navin Goyal, Dénes Csonka
Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed-dose combination tablets versus the use of single-component tablets in healthy subjects. Pharmacology research & perspectives 12 (3) (2024)
Jennifer Lynn Ford, Ahad Sabet, Jaya Natarajan, Hans Stieltjes, Daniel L Chao, Navin Goyal, Dénes Csonka
Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed-dose combination tablets versus the use of single-component tablets in healthy subjects. Pharmacology research & perspectives 12 (3) (2024)
Jennifer Lynn Ford, Ahad Sabet, Jaya Natarajan, Hans Stieltjes, Daniel L Chao, Navin Goyal, Dénes Csonka
Bioequivalence and the food effect of macitentan/tadalafil 10/20 fixed-dose combination tablets versus the use of single-component tablets in healthy subjects. Pharmacology research & perspectives 12 (3) (2024)
Dénes Csonka, Vladislav Fishman, Jaya Natarajan, Hans Stieltjes, Danielle Armas, Victor Dishy, Juan Jose Perez Ruixo
Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic. Pharmacology research & perspectives 9 (5) (2021)
Patricia N Sidharta, Radka Štěpánová, Susanne Globig, Ivan Ulč, Dénes Csonka
Relative bioavailability of a pediatric dispersible tablet and adult film-coated tablet of macitentan in healthy volunteers. Pharmacology research & perspectives 8 (2) (2021)
Simon Grill, Shirin Bruderer, Patricia N Sidharta, Mariya Antonova, Susanne Globig, James Carlson, Armin Schultz, Dénes Csonka
Bioequivalence of macitentan and tadalafil given as fixed-dose combination or single-component tablets in healthy subjects. British journal of clinical pharmacology 86 (12) (2020)
Dénes Csonka, Shirin Bruderer, Armin Schultz, Marianne Soergel, Radka Stepanova, Giancarlo Sabattini, Juan Jose Perez-Ruixo
Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects. Clinical drug investigation 39 (12) (2020)